pharma FDA Halts Regenxbio Gene Therapy Trial After Spinal Masses Found in Five Patients Aug 25, 2026, 10:28 PM
pharma Regenxbio Will Resubmit Hunter Syndrome Gene Therapy to FDA — No New Study Required Jun 22, 2026, 3:22 PM